JP2024534926A5 - - Google Patents
Info
- Publication number
- JP2024534926A5 JP2024534926A5 JP2024514495A JP2024514495A JP2024534926A5 JP 2024534926 A5 JP2024534926 A5 JP 2024534926A5 JP 2024514495 A JP2024514495 A JP 2024514495A JP 2024514495 A JP2024514495 A JP 2024514495A JP 2024534926 A5 JP2024534926 A5 JP 2024534926A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- months
- administered
- transplant
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241358P | 2021-09-07 | 2021-09-07 | |
| US63/241,358 | 2021-09-07 | ||
| PCT/EP2022/074646 WO2023036745A1 (en) | 2021-09-07 | 2022-09-05 | Method and composition for inducing tolerance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534926A JP2024534926A (ja) | 2024-09-26 |
| JP2024534926A5 true JP2024534926A5 (https=) | 2025-09-09 |
Family
ID=83438688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514495A Pending JP2024534926A (ja) | 2021-09-07 | 2022-09-05 | 寛容性を誘導するための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20240285756A1 (https=) |
| EP (1) | EP4398929A1 (https=) |
| JP (1) | JP2024534926A (https=) |
| AU (1) | AU2022342702A1 (https=) |
| CA (1) | CA3228514A1 (https=) |
| MX (1) | MX2024002811A (https=) |
| WO (1) | WO2023036745A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023008422A (es) * | 2021-01-25 | 2023-07-26 | Zelarion Malta Ltd | Metodo y composicion para inducir la tolerancia. |
| WO2025207763A1 (en) * | 2024-03-27 | 2025-10-02 | Zelarion Malta Limited | Method and composition for inducing tolerance of transplanted organ or tissue |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002250236A1 (en) | 2001-03-02 | 2002-09-19 | Medimmune, Inc. | Cd2 antagonists for treatment of autoimmune or inflammatory disease |
| JP6305443B2 (ja) * | 2013-02-26 | 2018-04-04 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 移植片の移植寛容のための組み合わされた臓器及び造血細胞 |
-
2022
- 2022-09-05 JP JP2024514495A patent/JP2024534926A/ja active Pending
- 2022-09-05 EP EP22776895.9A patent/EP4398929A1/en active Pending
- 2022-09-05 CA CA3228514A patent/CA3228514A1/en active Pending
- 2022-09-05 WO PCT/EP2022/074646 patent/WO2023036745A1/en not_active Ceased
- 2022-09-05 AU AU2022342702A patent/AU2022342702A1/en active Pending
- 2022-09-05 MX MX2024002811A patent/MX2024002811A/es unknown
-
2024
- 2024-01-26 US US18/424,381 patent/US20240285756A1/en not_active Abandoned
-
2025
- 2025-05-16 US US19/210,482 patent/US20250276061A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kebriaei et al. | A phase 3 randomized study of remestemcel-L versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease | |
| Post et al. | Immunosuppression in liver transplantation | |
| JP2024534926A5 (https=) | ||
| JP2002502824A (ja) | 同種移植における補刺激遮断および混合キメラ現象 | |
| FI3556774T3 (fi) | Anti-cd40-vasta-aineita ja niiden käyttötapoja | |
| JP2022512781A5 (https=) | ||
| Kanda et al. | Alemtuzumab for the prevention and treatment of graft-versus-host disease | |
| EP0680336B1 (fr) | Anticorps monoclonaux anti-lfa-1 pour la preparation d'un medicament destine a prevenir le rejet des greffes d'organes | |
| JP2014505056A5 (https=) | ||
| Kawai et al. | Summary of the third international workshop on clinical tolerance | |
| JP2019530728A5 (https=) | ||
| Barry | Immunosuppressive drugs in renal transplantation: a review of the regimens | |
| Gordon et al. | From experimental rat hindlimb to clinical face composite tissue allotransplantation: Historical background and current status | |
| JP2025515092A5 (https=) | ||
| Cendales et al. | Immunologic considerations in composite tissue transplantation: overview | |
| Nair et al. | Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients | |
| DE69737888T2 (de) | Anti-mhc klasse ii bindungsreagentien zur verwendung bei xenotransplantationen | |
| Gordon et al. | The evolution of composite tissue allotransplantation: the twentieth century realization of “Cosmas and Damian” | |
| JP2002530354A (ja) | 移植の拒絶反応の出現の処置に使用するためのｃｄ２５結合分子 | |
| US20030091541A1 (en) | Method of inducing immunotolerance in an organ transplantation recipient | |
| Kawai et al. | Induction of tolerance in clinical kidney transplantation | |
| CN111265664B (zh) | 用于预防和治疗急性移植物抗宿主病的组合物 | |
| Khosroshahi et al. | Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection | |
| TWI810555B (zh) | 移植病患之治療 | |
| Ishikawa et al. | Transplantation of ABO-incompatible and living unrelated donor–recipient combinations |